Company / Working Capital per Share
Ultragenyx Pharmaceutical Inc. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$6.13
FY2025
5-year range
$5.75 / $10.11
FY2021-FY2025
Trend
+6.7%
vs FY2024
Sector context
#90 of 210
Health Care
What the data says
At $6.13, Ultragenyx Pharmaceutical Inc.'s working capital per share ranks #90 of 210 in the Health Care sector. Working Capital per Share returned to growth in FY2025 after 4 years of decline, reaching $6.13.
Based on SEC 10-K filings.
6.13 in FY2025 with a 5-year CAGR of -20.3%.
Declined from $6.44 to $6.13 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -12.0%
- 5-Year CAGR
- -20.3%
- 10-Year CAGR
- -
Sector benchmark
#90 of 210 in Health CareTop 43% of 210This company $6.13 Sector average $146.86
▼
-95.8% below sector average
Key checks
Key Insights
- In FY2025, working capital per share increased 6.7% year-over-year.
- Ranks #90 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2020.
- Lowest working capital per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -2.91 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.13 | +6.7% |
| FY2024 | $5.75 | -10.7% |
| FY2023 | $6.44 | -28.3% |
| FY2022 | $8.98 | -11.1% |
| FY2021 | $10.11 | -47.1% |
| FY2020 | $19.12 | +30.0% |
| FY2019 | $14.70 | +45.1% |
| FY2018 | $10.14 | +110.5% |
| FY2017 | $4.81 | -45.2% |
| FY2016 | $8.78 | -23.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026